Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 106, Suchdauer: 3.87s

12 3 4 5 weiter »

1
Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status: Clinical Studies

von Pignata, S ; Oza, A ; Hall, G ; et al.

Schlagworte: olaparib; info:eu-repo/semantics/article
- Zum Volltext über OAIster
Merkliste

2
The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC

von Twelves, C. ; Bartsch, R. ; Ben-Baruch, N.E. ; et al.
- View full text via BASE
Merkliste

3
Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status: Clinical Studies

von Pignata S. ; Oza A. ; Hall G. ; et al.

Schlagworte: olaparib
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

4
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: Phase IIIb LUCY final analysis

von Gelmon, K. A. ; Walker, G. ; Baria, K. ; et al.
- View full text via BASE
Merkliste

5
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

von Balmana J. ; Fasching P. A. ; Couch F. J. ; et al.

Schlagworte: Breast cancer; Breast cancer 1 gene product; Breast cancer 2 gene product; Kaplan–Meier survival curve; Olaparib; Overall survival; Progression-free survival
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

6
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer

von Petrova, M P ; Donev, I S ; Radanova, M A ; et al.

Clinical and Experimental Immunology ; volume 202, issue 3, page 353-362 ; ISSN 0009-9104 1365-2249
- View full text via BASE
Merkliste

7
A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine

von Twelves, C ; Anthoney, A ; Savulsky, CI ; et al.
- View full text via BASE
Merkliste

8
Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial

von Pignata, S ; Oza, A ; Hall, G ; et al.

Schlagworte: BRCA mutation; HRR; Maintenance; Olaparib; Ovarian cancer
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

9
NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC

von de Castro, G., Jr. ; Rizvi, N.A. ; Schmid, P. ; et al.

Schlagworte: scientific_publication_article; Scientific publication - Journal Article
- Zum Volltext über OAIster
Merkliste

10
SAMANTHA: A European registry study to prospectively observe treatment patterns and outcomes in participants with HER2-positive unresectable locally advanced (LA) or metastatic breast cancer (mBC)

von Steger, G.G. ; Puglisi, F. ; Timcheva, C. ; et al.

Annals of Oncology ; volume 29, page viii119 ; ISSN 0923-7534
- View full text via BASE
Merkliste

11
Maintenance olaparib in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) by somatic (s) or germline (g) BRCA and other homologous recombination repair (HRR) gene mutation status: Overall survival (OS) results from the ORZORA study

von Pignata, S. ; Oza, A. M. ; Hall, G. ; et al.
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

12
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

von Gelmon K. A. ; Fasching P. A. ; Couch F. J. ; et al.

Schlagworte: BRCA1 gene; BRCA2 gene; Breast cancer; Effectivene; Germline mutation; Metastatic; Olaparib; Progression-free survival; Treatment outcome
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

13
482TiP Global, Phase 3 study of first-line durvalumab (MEDI4736) + tremelimumab vs standard of care platinum-based chemotherapy in advanced/metastatic NSCLC: NEPTUNE

von Mok, T. ; Schmid, P. ; de Castro, G. ; et al.

Annals of Oncology ; volume 27, page ix155 ; ISSN 0923-7534
- View full text via BASE
Merkliste

14
NEPTUNE: Phase III study of first-line durvalumab plus tremelimumab in patients with metastatic NSCLC

von de Castro, G., Jr. ; Rizvi, N. A. ; Schmid, P. ; et al.
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

15
480TiP Phase 3, randomised, open-label study of durvalumab (MEDI4736) in combination with tremelimumab versus platinum-based chemotherapy in first-line treatment of patients with advanced or metastatic NSCLC: NEPTUNE

von Mok, T. ; Schmid, P. ; Arén, O. ; et al.

Annals of Oncology ; volume 26, page ix125 ; ISSN 0923-7534
- View full text via BASE
Merkliste

16
Second-line targeted therapy of gastrointestinal stromal tumours

von Timcheva, C.

memo - Magazine of European Medical Oncology. June 2010 3(2):61-64
- Zum Volltext (via ReDI)
Merkliste

17
Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus Panel

von Steger, Guenther G. ; Abrahámová, Jitka ; Bacanu, Florin ; et al.

Wiener klinische Wochenschrift: The Middle European Journal of Medicine. June 2010 122(11-12):368-379
- Zum Volltext (via ReDI)
Merkliste

18
Factors influencing time to seeking medical advice and start of treatment in breast cancer (BC) patients - an International survey

von Timcheva, C. ; Zaborek, P. ; Stamatovic, L. ; et al.

Schlagworte: İç Hastalıkları; Onkoloji; Sağlık Bilimleri; Dahili Tıp Bilimleri; Tıp; Klinik Tıp (MED); Klinik Tıp; ONKOLOJİ
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

19
A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine

von Twelves C ; Anthoney A ; Savulsky CI ; et al.

British Journal of Cancer, 2019
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

20
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET). 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

von Martin M. ; Holmes F. A. ; Ejlertsen B. ; et al.

Schlagworte: exteNET; neratinib; pan-HER tyrosine kinase inhibitor
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

21
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

von Gligorov, J ; Ataseven, B ; Verrill, M ; et al.

Schlagworte: Adjuvant; Breast cancer; HER2/neu; Herceptin; Subcutaneou; Trastuzumab; info:eu-repo/semantics/article
- Zum Volltext über OAIster
Merkliste

22
Alternative (EGF 114299): a study of lapatinib, trastuzumab and endocrine therapy in patients who received neo-/adjuvant trastuzumab (IV) and endocrine therapy

von Gradishar, WJ ; Kahan, Z ; Tsang, J ; et al.

Schlagworte: Medical sciences; Oncology medical sciences; Radiology and nuclear medicine pharmacy and pharmacology biology; Cytology and histology
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

23
583: Recurrent BRCA1/2 mutations in Bulgarian patients with hereditary breast and ovarian cancer

von Dodova, R. ; Mitkova, A. ; Dacheva, D. ; et al.

European Journal of Cancer ; volume 50, page S140 ; ISSN 0959-8049
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

24
695 Mutation Screening of BRCA1 Gene in Bulgarian Breast Cancer Patients

von Dodova, R. ; Dacheva, D. ; Vlahova, A. ; et al.

European Journal of Cancer ; volume 48, page S164 ; ISSN 0959-8049
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

25
546 Mutation Screening of BRCA2 Exon 11 and Exon 17 in Bulgarian Breast Cancer Patients

von Dacheva, D. ; Dodova, R. ; Mitkova, A. ; et al.

European Journal of Cancer ; volume 48, page S129 ; ISSN 0959-8049
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

12 3 4 5 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag